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Background:  Conventional cardiac troponin (cTn) assays are not sensitive to detect low levels of cTn present in patients with stable coronary 
artery disease (CAD). We used a new cTnT assay that is 10 time more sensitive than the conventional one. We hypothesized that low levels of cTnT 
can predict angiographic CAD in patients without acute coronary syndromes.
Methods:  High-sensitivity cTnT (hs-cTnT) was measured in 182 consecutive patients referred for coronary angiography. Patients with known CAD or 
with acute coronary syndromes or elevated conventional cTn were excluded. Creatinine clearance was calculated using the Cockcroft-Gault equation. 
Patients were divided in 4 groups according to angiographic results  normal (< 10% stenosis; n = 36), mild (11%-50% stenosis; n = 52), moderate 
(51%-70% stenosis; n = 14) and severe CAD (> 70% stenosis; n = 80).
Results:  Mean age was 60 + 11 years and 69% of patients were male. Indication for coronary angiography was chest pain of possible cardiac 
etiology with normal resting ECG in 100 patients (55%), ischemia on resting ECG or on non invasive testing in 69 patients (38%) and planned valve 
surgery in the remaining 13 patients (7%). hs-cTnT levels were detectable in 87% of the patients (median 7 pg/mL; IQR: 5-11 pg/mL). hs-cTnT had 
a graded relationship with the presence and severity of CAD being lowest in patients with normal arteries (5 pg/mL, IQR 3-7), intermediate in those 
with mild disease (6.5 pg/mL, IQR 4.2-9) and in those with moderate disease (7 pg/mL, IQR 4.7-12) and highest in patients with severe disease (9 
pg/mL, IQR 6-14; p < 0.001). The relative risks for severe CAD were 2.4 (95% CI 1.4-4.2; p = 0.001), 2 (95% CI 1.2-3.7; p = 0.009) and 1.3 (95% 
CI 0.65-2.6; p= ns) for quartiles 4, 3 and 2 of hs-cTnT respectively, vs. quartile 1 (p for trend = 0.001). In a multivariate analysis which included the 
univariate predictors of CAD (age, gender, hypertension, hyperlipidemia, family history of CAD, creatinine clearance and hs-cTnT), Log hs-cTnT was the 
most important predictor for the presence of severe CAD (Odds ratio 2.4, 95% CI 1.26 - 4.5; p = 0.007).
Conclusions:  In stable patients referred for coronary angiography, hs-cTnT is an independent predictor of CAD.
